2018 annual financial data
Akebia Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -46.93%.
Operating income was -178,139,000 USD and net income was -171,904,000 USD.
Operating cash flow was -97,494,000 USD.
Get free Akebia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 207,742,000 USD
- Operating income
- -178,139,000 USD
- Net income
- -171,904,000 USD
- Operating cash flow
- -97,494,000 USD